In line with these reports, our findings also revealed downregulation in PBMCs of TMSB4X, SRSF6, THBS1, CUL4A, and S100A9 genes in patients at the early stage, suggesting an inverse correlation between their expression in tumor tissues and PBMCs of the primary stage patients. This evidence concerns the gene SRSF6 and neoplasm.